We propose the ?Automated detection and prediction of atrial fibrillation during sepsis? study to develop automated technologies capable of accurate atrial fibrillation (AF) detection and prediction during sepsis. Sepsis is a life-threatening, dysregulated response to infection and the most common illness leading to hospitalization in the United States, affecting ~1 million Americans yearly, and is associated with 50% of all hospital deaths. With the exception early antibiotic and fluid use, few therapies improve outcomes among septic patients; new treatment strategies are greatly needed to improve survival. New-onset AF is a common dysrhythmia among critically ill patients with sepsis, affecting up to 1 in 3 septic patients and conferring increased short- and long-term risks stroke, heart failure, and death. Prevention of AF or its complications may improve sepsis outcomes by reducing AF-related morbidity and mortality. Although several evidence-based treatments have shown efficacy in treating and preventing AF in certain high-risk subgroups (e.g., AF prevention following cardiac surgery), studying application of these therapies among critically ill patients with sepsis has been hampered by two major factors: 1) we lack validated automated mechanisms to detect AF and facilitate real-world AF research in large clinical databases, and 2) we cannot presently predict which patients with sepsis will develop AF. Our project will leverage the unique resources of the recently released Multiparameter Intelligent Monitoring in Intensive Care (MIMIC III) database. MIMIC III links continuous ECG and pulse plethysmographic waveforms to a wealth of time-varying clinical and hemodynamic data. Our project will develop and validate state-of-the art automated AF detection algorithms using waveform data from critically ill patients. Automated AF detection would enable expedited clinical treatment of AF, identification of subclinical AF, and will catalyze the study of AF in emerging electronic health record waveform databases. We will develop innovative automated AF prediction capabilities using state-of-the-art waveform analysis algorithms and machine learning methods in critically ill patients. Automated algorithms that identify patients at high risk for developing AF in the near-term would enable targeting of preventative therapies and potentially usher in a new era of AF prevention for critically ill patients. AF prevention and treatment facilitated through our project will allow targeting of novel, AF-based mechanisms of poor outcomes during and following sepsis.

Public Health Relevance

Sepsis is a dysregulated response to infection that causes life-threatening organ dysfunction that affects nearly 1 million Americans each year. Atrial fibrillation is a form of cardiac dysfunction that occurs during sepsis characterized by abnormal heart rhythm, loss of normal atrial contraction, rapid heart rates, heart failure, shock and increased risk for stroke. Our proposal seeks to develop automated methods for the detection and prediction of atrial fibrillation during sepsis, methods that will enhance our future ability to prevent and treat atrial fibrillation to avoid its life-threatening consequences.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL136660-02
Application #
9418100
Study Section
Biomedical Computing and Health Informatics Study Section (BCHI)
Program Officer
Shi, Yang
Project Start
2017-04-01
Project End
2021-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
Law, Anica C; Sahetya, Sarina; Walkey, Allan J et al. (2018) Low-dose corticosteroids and septic shock resolution: implications for randomized trial design? Intensive Care Med 44:1366-1367
Law, Anica C; Stevens, Jennifer P; Hohmann, Samuel et al. (2018) Patient Outcomes After the Introduction of Statewide ICU Nurse Staffing Regulations. Crit Care Med 46:1563-1569
Walkey, Allan J; Drainoni, Mari-Lynn; Cordella, Nicholas et al. (2018) Advancing Quality Improvement with Regression Discontinuity Designs. Ann Am Thorac Soc 15:523-529
Walkey, Allan; Adhikari, Neill Kj; Day, Andrew G et al. (2018) Mediation Analysis of High Blood Pressure Targets, Arrhythmias, and Shock Mortality. Am J Respir Crit Care Med :
Staerk, Laila; Wang, Biqi; Preis, Sarah R et al. (2018) Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ 361:k1453
Alcusky, Matthew; Hume, Anne L; Fisher, Marc et al. (2018) Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging 35:1089-1098
Quinton, Lee J; Walkey, Allan J; Mizgerd, Joseph P (2018) Integrative Physiology of Pneumonia. Physiol Rev 98:1417-1464
Walkey, Allan J; Shieh, Meng-Shiou; Liu, Vincent X et al. (2018) Mortality Measures to Profile Hospital Performance for Patients With Septic Shock. Crit Care Med 46:1247-1254
Liu, Vincent X; Walkey, Allan J (2017) Machine Learning and Sepsis: On the Road to Revolution. Crit Care Med 45:1946-1947
Walkey, Allan J; Lindenauer, Peter K (2017) Keeping It Simple in Sepsis Measures. J Hosp Med 12:1019-1020